Skip to main content

People in the News: Tim Cooley, Kevin Krenzke, Ardy Arianpour

Premium

MolecularHealth has added two new members to its US executive team: Tim Cooley and Kevin Krenzke.

Cooley will be senior VP of IT at MolecularHealth. He previously spent 15 years at Eli Lilly, where he held various positions, including director of IT. Krenzke will be senior VP of finance at MolecularHelath. He joins the firm after holding leaderships roles at McKesson Specialty Health and US Oncology.

The new additions to the MolecularHealth team come as the company is readying to launch TreatmentMAP, a cancer treatment decision support tool, in the first quarter.


Ardy Arianpour has joined Pathway Genomics as chief strategy officer, the company said this week.
Arianpour most recently was senior VP of business development at Ambry Genetics, and during his 13-year career in the biotech sector he also has worked in senior sales and business development roles at Clinical Data, Cogenics, and Eurogentec North America. In his new post, Arianpour will lead the San Diego-based company's global strategy, strategic planning, and partnership activities.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.